A multiinstitutional review of 3778 patients with a primary malignancy of the urinary bladder
revealed 18 cases (0.48%) of small cell carcinoma which were histologically and …

Patients with previously untreated category T3 to T4 Mo or Ml prostatic cancer were
allocated randomly to receive 250 mg. cyproterone acetate per day, a loading dose of 500 …

Two randomized trials were started in 1976 by the European Organization for Research on
Treatment of Cancer urological group. Trial 30761 compared 1 mg. diethylstilbestrol orally 3 …

Cyproterone acetate is a steroidal anti‐androgen that blocks the androgen‐receptor
interaction and reduces serum testosterone through its weak anti‐gonadotropic action. It can …

Abstract The European Organization for Research on Treatment of Cancer Genitourinary
Group performed a multivariate statistical analysis of prognostic factors based on 436 …

This is the final analysis of EORTC GU Group Trial 30843 in which the treatment of
advanced, metastatic prostate cancer with a combination of the LHRH agonist buserelin …

Urinary calculi can induce urothelial cellular abnormalities comparable with those of
malignancy; this was found in 11 out of 62 lithiasis cases. Severe cellular changes …

The sensitivity and specificity of urinary cytology in the detection of urothelial tumours using
voided urine and applying simple smear preparation and staining techniques have been …

In 80 patients with primary superficial bladder carcinoma Tumor Nodes Metastasis (TNM
classification: stages Ta and T1) with adequate follow-up of at least four years, the value of …

Small cell carcinoma with the histological appearance of pulmonary small cell carcinoma is
a rare tumour in the urinary bladder. In previous case reports the neuroendocrine nature of …